CLS Holdings USA, Inc. (CLSH)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CLS Holdings USA, Inc. (CLSH) with AI Score 43/100 (Weak). CLS Holdings USA, Inc. is a diversified cannabis company focused on cannabinoid extraction and conversion. The company sells cannabis products under the Oasis Cannabis and City Trees brands. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026CLS Holdings USA, Inc. (CLSH) Healthcare & Pipeline Overview
CLS Holdings USA, Inc. operates in the cannabis industry, focusing on the extraction and conversion of cannabinoids into various products. The company sells to licensed retailers and distributors under the Oasis Cannabis and City Trees brands, offering concentrates, edibles, and consulting services within the United States.
Investment Thesis
CLS Holdings USA, Inc. presents a speculative investment opportunity within the cannabis sector, characterized by its focus on extraction and branded product sales. With a market capitalization of $0.01 billion and a negative P/E ratio of -16.20, the company's financial performance indicates challenges in achieving profitability. A gross margin of 41.4% suggests potential for operational efficiency, but the negative profit margin of -4.6% highlights the need for improved cost management. Growth catalysts include expansion of its product lines and increased market penetration in existing and new geographic areas. However, investors may want to evaluate the risks associated with the OTC market, regulatory uncertainties, and competition within the cannabis industry. The company's beta of 1.18 indicates higher volatility compared to the overall market.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.01 billion reflects the company's small size and potential for growth or volatility.
- Gross margin of 41.4% indicates a reasonable level of efficiency in production and sales.
- Negative P/E ratio of -16.20 suggests the company is currently not profitable.
- Profit margin of -4.6% highlights the need for improved cost management and revenue generation.
- Beta of 1.18 indicates the stock is more volatile than the overall market.
Competitors & Peers
Strengths
- Diversified cannabis product offerings.
- Established brands (Oasis Cannabis and City Trees).
- Expertise in cannabinoid extraction and conversion.
- Provision of consulting services.
Weaknesses
- Small market capitalization.
- Negative profitability.
- Limited geographic reach.
- Reliance on the regulatory environment in specific states.
Catalysts
- Upcoming: Potential changes in cannabis regulations at the state or federal level could create new market opportunities.
- Ongoing: Expansion of the company's product lines to include new cannabis-infused products.
- Ongoing: Strategic partnerships with other cannabis companies to expand market reach.
- Ongoing: Increased focus on branding and marketing to drive customer awareness and loyalty.
Risks
- Ongoing: Intense competition in the cannabis industry could pressure margins and market share.
- Potential: Fluctuations in cannabis prices could impact revenue and profitability.
- Ongoing: Changing regulatory landscape could create uncertainty and compliance costs.
- Potential: Limited access to capital could hinder growth initiatives.
- Ongoing: Risks associated with operating on the OTC market, including lower liquidity and higher volatility.
Growth Opportunities
- Expansion of Product Lines: CLS Holdings has the opportunity to expand its product lines to include new cannabis-infused products, catering to evolving consumer preferences. The market for cannabis edibles and concentrates is projected to grow significantly, offering potential for increased revenue. By introducing innovative products and formulations, CLS Holdings can attract new customers and increase its market share. This expansion could involve developing new flavors, dosages, or delivery methods, such as vape pens or topical creams. The timeline for this growth opportunity is immediate, with ongoing product development efforts.
- Geographic Expansion: CLS Holdings can pursue geographic expansion by entering new markets and establishing operations in states with favorable cannabis regulations. The cannabis market is expanding across the United States, with more states legalizing medical and recreational use. By strategically targeting new markets, CLS Holdings can increase its customer base and revenue streams. This expansion could involve establishing new cultivation facilities, processing plants, or retail locations. The timeline for this growth opportunity is medium-term, with potential for expansion over the next 2-3 years.
- Strategic Partnerships: CLS Holdings can form strategic partnerships with other cannabis companies, including cultivators, distributors, and retailers, to expand its reach and market presence. These partnerships can provide access to new markets, technologies, and resources, enabling CLS Holdings to accelerate its growth. For example, CLS Holdings could partner with a large-scale cultivator to secure a reliable supply of cannabis or with a retail chain to distribute its products. The timeline for this growth opportunity is ongoing, with potential for partnerships to be formed at any time.
- Increased Focus on Branding: CLS Holdings can invest in branding and marketing efforts to increase awareness of its Oasis Cannabis and City Trees brands and differentiate its products from competitors. A strong brand can create customer loyalty and increase sales. This could involve developing a consistent brand identity, launching marketing campaigns, and engaging with customers through social media and events. The timeline for this growth opportunity is ongoing, with continuous efforts to build brand awareness and loyalty.
- Development of Proprietary Strains: CLS Holdings can develop proprietary cannabis strains with unique characteristics and effects, creating a competitive advantage in the market. Proprietary strains can command premium prices and attract customers seeking specific experiences. This could involve investing in research and development to breed new strains with desired traits, such as high potency, unique flavors, or specific medical benefits. The timeline for this growth opportunity is long-term, with potential for new strains to be developed over the next 3-5 years.
Opportunities
- Expansion into new geographic markets.
- Development of new cannabis-infused products.
- Strategic partnerships with other cannabis companies.
- Increased focus on branding and marketing.
Threats
- Intense competition in the cannabis industry.
- Changing regulatory landscape.
- Fluctuations in cannabis prices.
- Limited access to capital.
Competitive Advantages
- Established brands (Oasis Cannabis and City Trees).
- Expertise in cannabinoid extraction and conversion.
- Relationships with licensed retailers and distributors.
- Consulting services provide additional revenue streams and customer relationships.
About CLSH
CLS Holdings USA, Inc., founded in 2014 and based in Las Vegas, Nevada, operates as a diversified cannabis company specializing in the extraction and conversion of cannabinoids. The company's core business involves extracting cannabinoids from cannabis plants and transforming them into concentrates such as oils, waxes, edibles, and shatters. These products are marketed under the Oasis Cannabis and City Trees brand names. CLS Holdings serves licensed retailers and distributors, offering organic medical cannabis and recreational marijuana cannabis products. In addition to its branded product lines, CLS Holdings provides extraction services for licensed medical cannabis cultivators and sells cannabis strains in vegetative cuttings. The company also offers consulting services to cannabis-related businesses, including growers, dispensaries, and laboratories, as well as toll processing services. CLS Holdings' concentrates are utilized for both pharmaceutical and other purposes, demonstrating the company's diversified approach within the cannabis market.
What They Do
- Extracts cannabinoids from cannabis plants.
- Converts cannabinoids into concentrates like oils, waxes, and edibles.
- Sells organic medical cannabis to licensed retailers.
- Sells recreational marijuana cannabis products to licensed distributors and retailers.
- Offers extraction products derived from in-house cannabis production.
- Provides processing and extraction services for licensed medical cannabis cultivators.
- Sells cannabis strains in the form of vegetative cuttings to licensed medical cannabis cultivators.
- Offers consulting services to cannabis-related businesses.
Business Model
- Extraction and conversion of cannabinoids into various products.
- Sales of branded cannabis products under Oasis Cannabis and City Trees.
- Provision of extraction and processing services to other cannabis businesses.
- Consulting services for cannabis-related businesses.
Industry Context
CLS Holdings USA, Inc. operates within the rapidly evolving cannabis industry, which is experiencing significant growth and regulatory changes. The market is characterized by increasing acceptance of cannabis for both medical and recreational use, driving demand for various cannabis products. CLS Holdings competes with other cannabis companies, including ACRDF, ACRHF, BCBCF, CHNC, and FFLWF, focusing on extraction, product development, and distribution. The industry faces regulatory hurdles, varying state laws, and intense competition, requiring companies to adapt and innovate to maintain a competitive edge. Market trends include the increasing popularity of cannabis concentrates and edibles, as well as the expansion of cannabis retail networks.
Key Customers
- Licensed cannabis retailers.
- Licensed cannabis distributors.
- Licensed medical cannabis cultivators.
- Cannabis-related businesses (growers, dispensaries, laboratories).
Financials
Chart & Info
CLS Holdings USA, Inc. (CLSH) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
· Mar 24, 2020
-
Stocks That Hit 52-Week Lows On Thursday
· Feb 27, 2020
-
Stocks That Hit 52-Week Lows On Thursday
· Feb 20, 2020
-
New 52-Week Lows for Tuesday Morning
· Jul 30, 2019
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CLSH.
Price Targets
Wall Street price target analysis for CLSH.
MoonshotScore
What does this score mean?
The MoonshotScore rates CLSH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Andrew J. Glashow
CEO
Andrew J. Glashow serves as the CEO of CLS Holdings USA, Inc., leading the company's strategic direction and operations. His background includes experience in managing teams and driving growth within the cannabis industry. He is responsible for overseeing the company's extraction, production, and sales activities, as well as its consulting services. Glashow's leadership is focused on expanding CLS Holdings' market presence and developing innovative cannabis products. His expertise in the cannabis sector is pivotal to navigating the complex regulatory landscape and capitalizing on growth opportunities.
Track Record: Under Andrew J. Glashow's leadership, CLS Holdings has focused on expanding its product lines and increasing its market share in the cannabis industry. He has overseen the development and launch of new cannabis-infused products, as well as the expansion of the company's consulting services. His strategic decisions have aimed at improving operational efficiency and driving revenue growth. However, the company's profitability remains a challenge.
CLSH OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing securities that are not eligible for quotation on OTCQX or OTCQB. These securities may include those of companies that are unwilling or unable to meet the financial reporting standards or other requirements for higher tiers. Companies on the OTC Other tier may have limited information available to investors, and trading in these securities can be highly speculative. This tier often includes defunct companies, shell corporations, and companies with questionable business practices.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited information availability due to lower disclosure requirements.
- Higher potential for fraud and manipulation.
- Lower liquidity and wider bid-ask spreads.
- Greater price volatility.
- Increased risk of delisting or company failure.
- Verify the company's financial reporting status and access any available financial statements.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Review any available news articles or press releases about the company.
- Check for any regulatory filings or legal proceedings involving the company.
- Understand the risks associated with investing in OTC Other stocks.
- Consult with a financial advisor before making any investment decisions.
- The company has been in operation since 2014.
- The company has established brands (Oasis Cannabis and City Trees).
- The company has a team of 80 employees.
- The company provides extraction and consulting services, indicating some level of expertise.
CLSH Healthcare Stock FAQ
What does CLS Holdings USA, Inc. do?
CLS Holdings USA, Inc. is a diversified cannabis company focused on the extraction and conversion of cannabinoids into various products. The company extracts cannabinoids from cannabis plants and transforms them into concentrates such as oils, waxes, and edibles. These products are sold under the Oasis Cannabis and City Trees brands to licensed retailers and distributors. CLS Holdings also provides extraction and processing services to other cannabis businesses, as well as consulting services to cannabis-related companies.
What do analysts say about CLSH stock?
AI analysis is currently pending for CLSH stock. Due to its OTC listing and small market capitalization, CLS Holdings USA, Inc. may not be widely covered by analysts. Investors should conduct their own due diligence and consider the risks associated with investing in OTC stocks. Key valuation metrics to consider include revenue growth, gross margin, and profitability. Growth considerations include the company's ability to expand its product lines, enter new markets, and form strategic partnerships.
What are the main risks for CLSH?
The main risks for CLS Holdings USA, Inc. include intense competition in the cannabis industry, which could pressure margins and market share. The changing regulatory landscape creates uncertainty and compliance costs. Fluctuations in cannabis prices could impact revenue and profitability. Limited access to capital could hinder growth initiatives. Operating on the OTC market poses additional risks, including lower liquidity and higher volatility. Investors should carefully consider these risks before investing in CLSH.
What are the key factors to evaluate for CLSH?
CLS Holdings USA, Inc. (CLSH) currently holds an AI score of 43/100, indicating low score. Key strength: Diversified cannabis product offerings.. Primary risk to monitor: Ongoing: Intense competition in the cannabis industry could pressure margins and market share.. This is not financial advice.
How frequently does CLSH data refresh on this page?
CLSH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven CLSH's recent stock price performance?
Recent price movement in CLS Holdings USA, Inc. (CLSH) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified cannabis product offerings.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider CLSH overvalued or undervalued right now?
Determining whether CLS Holdings USA, Inc. (CLSH) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying CLSH?
Before investing in CLS Holdings USA, Inc. (CLSH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available sources and may be subject to change.
- OTC stocks carry higher risks than exchange-listed stocks.
- AI analysis is pending and may provide additional insights.